The Office of the US Trade Representative will attempt to resolve issues raised by US medtech companies about India's price controls on medical devices, as well as intellectual property disputes, Trade Representative Robert Lighthizer said at a Senate Finance Committee hearing on trade policy. Lighthizer added that enforcement actions will be taken if India's actions are proven to have violated World Trade Organization rules.
Trade office: India may face enforcement actions over medtech price controls
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.